IQVIA Holdings Inc. (LON:0JDM)

Oncternal Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	22,728	28,489	33,151	31,585	39,806	25,160
Market Cap Growth	-34.72%	-14.06%	4.96%	-20.65%	58.21%	11.15%
Enterprise Value	32,811	38,266	43,082	40,957	47,900	33,787
Last Close Price	132.80	156.89	180.76	168.12	209.56	128.46
PE Ratio	25.17	25.98	31.10	34.88	55.80	123.12
PS Ratio	1.98	2.32	2.82	2.64	3.89	3.02
PB Ratio	5.38	5.88	6.91	6.60	8.92	5.47
P/FCF Ratio	15.49	16.87	28.15	24.00	23.41	25.58
P/OCF Ratio	11.90	13.13	19.65	16.84	18.32	17.54
EV/Sales Ratio	2.81	3.11	3.66	3.43	4.68	4.06
EV/EBITDA Ratio	14.37	16.40	20.17	19.19	25.95	25.21
EV/EBIT Ratio	19.49	21.02	26.50	26.53	44.85	56.95
EV/FCF Ratio	22.36	22.66	36.58	31.12	28.18	34.35
Debt / Equity Ratio	2.72	2.39	2.28	2.26	2.06	2.06
Debt / EBITDA Ratio	5.11	4.70	4.84	4.75	4.64	6.36
Debt / FCF Ratio	7.83	6.85	9.30	8.20	5.41	9.65
Asset Turnover	0.57	0.57	0.58	0.58	0.56	0.48
Quick Ratio	0.74	0.73	0.76	0.77	0.78	0.96
Current Ratio	0.84	0.84	0.86	0.89	0.91	1.12
Return on Equity (ROE)	19.79%	22.55%	22.87%	18.48%	15.76%	4.91%
Return on Assets (ROA)	5.16%	5.32%	4.98%	4.65%	3.67%	2.12%
Return on Capital (ROIC)	6.79%	7.02%	6.67%	6.24%	4.79%	2.70%
Return on Capital Employed (ROCE)	10.80%	11.40%	10.30%	9.40%	7.40%	4.00%
Earnings Yield	3.97%	3.85%	3.22%	2.87%	1.79%	0.81%
FCF Yield	6.45%	5.93%	3.55%	4.17%	4.27%	3.91%
Buyback Yield / Dilution	3.11%	1.56%	2.26%	2.26%	-0.05%	2.31%

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.